home / stock / adag / adag news

ADAG News and Press, Adagene Inc. From 01/04/24

Stock Information
Company Name: Adagene Inc.
Stock Symbol: ADAG
Market: NASDAQ
Menu
ADAG ADAG Quote ADAG Short ADAG News ADAG Articles ADAG Message Board
Get ADAG Alerts

News, Short Squeeze, Breakout and More Instantly...
ADAG - Adagene To Present Interim Results of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at ASCO-GI Symposium

- Interim results in MSS CRC suggest that SAFEbody precision masking technology enables a new standard for anti-CTLA-4 therapy at higher, more frequent and repeat doses by overcoming longtime safety-limited efficacy challenges with this proven immunotherapy target - SAN DIEGO an...
ADAG - Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 at SITC 2023

- MSS CRC case examples reinforce optimal dosing regimen in ongoing phase 2 dose expansion, with a confirmed partial response at ADG126 10 mg/kg every three weeks plus pembrolizumab – - Integrated pharmacokinetic and clinical data analyses support the mechanism of action for ADG1...

ADAG - Adagene Announces Poster Presentation on Optimal Dose Selection for Masked Anti-CTLA-4 SAFEbody® ADG126 at Upcoming Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

- Data reinforces mechanism of action and selection of 10 mg/kg every three weeks repeat dosing regimen with pembrolizumab in ongoing MSS CRC dose expansion cohort – SAN DIEGO and SUZHOU, China, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), ...

ADAG - ,EVA, GRTS and SLGL are among mid-day movers

2023-10-06 13:29:08 ET Gainers: Falcon's Beyond Global  (FBYD) +145% . American Oncology Network  ( AONC ) +53% . Akso Health Group  ( AHG ) +23% . Vigil Neuroscience  ( VIGL ) +20% . NuScale Power Corporation ( SMR )...
ADAG - Adagene to Present at Investor and Scientific Conferences in September

– Adagene’s CEO, Dr. Peter Luo, participating in SITC webinar on September 22 focused on essential role of Treg depletion for anti-CTLA-4 therapies – SAN DIEGO and SUZHOU, China, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a...

ADAG - Adagene reports 1H results

2023-08-31 12:03:53 ET More on Adagene ADR Adagene adds 12% on clinical trial collaboration with Roche Adagene, Merck gets FDA clearance to advance ADG126/Keytruda combo in solid tumor study Sanofi in multi-billion-dollar deal with Adagene for immuno-oncology candida...

ADAG - Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update

- Best-in-class anti-CTLA-4 candidates designed for more than 30-fold increase in therapeutic index, addressing patient populations where CTLA-4-mediated Treg depletion is essential for efficacy – - Strong efficacy signal observed in MSS CRC phase 2 single arm study for SAFEbody ...
ADAG - MULN, YELL and ACIU among mid-day movers

2023-06-27 13:14:58 ET Gainers: AC Immune ( ACIU ) +48% . Tivic Health Systems ( TIVC ) +47% . The Arena Group Holdings ( AREN ) +27% . Ispire Technology ( ISPR ) +21% . Enovix Corporation ( ENVX ) +20% . Advanced Health Inte...

ADAG - Black Diamond, Cara top healthcare gainers; Adicet, Nkarta among losers

2023-06-27 10:07:53 ET Gainers: Black Diamond Therapeutics ( BDTX ) +91% . Cara Therapeutics ( CARA ) +27% . Pharvaris ( PHVS ) +21% . AC Immune ( ACIU ) +11% . Immix Biopharma ( IMMX ) +6% . Losers: Adicet Bio ( ACET ...

ADAG - Adagene Achieves $3 Million Milestone in Collaboration with Exelixis for Successful Nomination of Second SAFEbody® Novel Masked Antibody-Drug Conjugate

SAN DIEGO and SUZHOU, China, May 04, 2023 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies today announced achievement of a milestone in i...
Previous 10 Next 10